Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2010
Total Assets: $1.73B
Liabilities Breakdown FY2010
Total Liabilities: $1.22B
Asset Breakdown
Total Assets: $1.73B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $243.2M | 14.1% |
| Accounts Receivable | $12.5M | 0.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $72.3M | 4.2% |
| Goodwill | $26.1M | 1.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.37B | 79.5% |
Liabilities Breakdown
Total Liabilities: $1.22B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $35.9M | 2.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.19B | 97.1% |